Israeli - Kiingereza - Ministry of Health

reckitt benckiser (near east) ltd - ibuprofen - suppositories - ibuprofen 60 mg - ibuprofen - ibuprofen - for the symptomatic treatment of mild to moderate pain. for the symptomatic treatment of fever.

Israeli - Kiingereza - Ministry of Health

reckitt benckiser (near east) ltd - ibuprofen - suppositories - ibuprofen 125 mg - ibuprofen - ibuprofen - for the symptomatic treatment of muld to moderate pain. for the symptomatic treatment of fever.

Israeli - Kiingereza - Ministry of Health

padagis israel agencies ltd, israel - infliximab - solution for injection - infliximab 120 mg/ml - infliximab - rheumatoid arthritis: remsima, in combination with methotrexate, is indicated for the reduction of signs and symptoms as well as the improvement in physical function in:•adult patients with active disease when the response to disease-modifying antirheumatic drugs (dmards),including methotrexate, has been inadequate. •adult patients with severe, active and progressive disease not previously treated with methotrexate or other dmards. in these patient populations, a reduction in the rate of the progression of joint damage, as measured by x ray,has been demonstrated.crohn’s diseaseremsima is indicated for:• treatment of moderately to severely active crohn’s disease, in adult patients who have not responded despite a full and adequate course of therapy with a corticosteroid and/or an immunosuppressant; or who are intolerant to or have medical contraindications for such therapies.• treatment of fistulising, active crohn’s disease, in adult patients who have not responded despite a full and adequate course of therapy with conventional treatment (including antibiotics, drainage and immunosuppressive therapy).ulcerative colitisremsima is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine (6-mp) or azathioprine (aza), or who are intolerant to or have medical contraindications for such therapies.ankylosing spondylitisremsima is indicated for treatment of severe, active ankylosing spondylitis, in adult patients who have responded inadequately to conventional therapy.psoriatic arthritisremsima is indicated for treatment of active and progressive psoriatic arthritis in adult patients when the response to previous dmard therapy has been inadequate.remsima should be administered• in combination with methotrexate• or alone in patients who show intolerance to methotrexate or for whom methotrexate is contraindicated. infliximab has been shown to improve physical function in patients with psoriatic arthritis, and to reduce the rate of progression of peripheral joint damage as measured by x-ray in patients with polyarticular symmetrical subtypes of the disease.psoriasisremsima is indicated for treatment of moderate to severe plaque psoriasis in adult patients who failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapy including ciclosporin, methotrexate or psoralen ultra-violet a (puva).

Israeli - Kiingereza - Ministry of Health

astrazeneca (israel) ltd - rosuvastatin as calcium - film coated tablets - rosuvastatin as calcium 10 mg - rosuvastatin - rosuvastatin - treatment of adults with:• primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.• homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate

Israeli - Kiingereza - Ministry of Health

astrazeneca (israel) ltd - rosuvastatin as calcium - film coated tablets - rosuvastatin as calcium 20 mg - rosuvastatin - rosuvastatin - treatment of adults with:• primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.• homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate

Israeli - Kiingereza - Ministry of Health

astrazeneca (israel) ltd - rosuvastatin as calcium - film coated tablets - rosuvastatin as calcium 40 mg - rosuvastatin - rosuvastatin - treatment of adults with:• primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.• homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate

Israeli - Kiingereza - Ministry of Health

bayer israel ltd - mesterolone - tablets - mesterolone 25 mg - mesterolone - mesterolone - androgen therapy. androgen deficiency or male infertility when associated with primary or secondary male hypogonadism.

Israeli - Kiingereza - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - fluconazole - solution for infusion - fluconazole 2 mg/ml - fluconazole - fluconazole - fluconazole is indicated in the following fungal infections .fluconazole is indicated in adults for the treatment of:• cryptococcal meningitis .• coccidioidomycosis . invasive candidiasis.• mucosal candidiasis (including oropharyngeal candidiasis, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis).• chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene topical treatment are insufficient.fluconazole is indicated in adults for the prophylaxis of:• relapse of cryptococcal meningitis in patients with high risk of recurrence.• relapse of oropharyngeal or oesophageal candidiasis in patients infected with hiv who are at high risk of experiencing relapse.• prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving haematopoetic stem cell transplantation ).fluconazole is indicated in term newborn infants, infants, toddlers, children and adolescents aged from 0 to 17 years old:fluconazole is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence.therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly.consideration should be given to official guidance on the appropriate use of antifungals.

Israeli - Kiingereza - Ministry of Health

dexcel ltd, israel - iomeprol - solution for injection - iomeprol 612.4 mg/ml - iomeprol - iomeprol - contrast medium for diagnostic radiology. intravenous urography ( in adults and paediatrics), peripheral phlebography, ct (brain and body), cavernosography, intravenous dsa, conventional angiography, intraarterial dsa, angiocardiography (in adults and paediatrics), conventional selective coronary arteriography, interventional coronary arteriography, ercp, arthrography, hysterosalpingography, fistulography, discography, galactography, chloangiography, dacryocystography, sialography, retrograde urethrography, retrograde pyelo-ureterography.

Israeli - Kiingereza - Ministry of Health

dexcel ltd, israel - iomeprol - solution for injection - iomeprol 714.4 mg/ml - watersoluble, nephrotropic, low osmolar x-ray contrast media - contrast medium for diagnostic radiography. intravenous urography (in adults and pediatrics), ct (body), intravenous dsa, conventional angiography, intraarterial dsa, angiocardiography (in adults and pediatrics), conventional selective coronary arteriography, interventional coronary arteriography , arthrography, hysterosalpingography, fistulography, galactography, retrograde chloangiography, dacryocystography, sialography.